Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics (Q24811190)

4

object named as

Christoph Correll

0 references

John M. Kane

5

object named as

John Kane

0 references

author name string

Douglas Faries

1

0 references

Baojin Zhu

A comparison of olanzapine and risperidone on the risk of psychiatric hospitalization in the naturalistic treatment of patients with schizophrenia

3

0 references

language of work or name

English

0 references

publication date

2005

0 references

published in

BMC Psychiatry

0 references

volume

5

0 references

issue

1

0 references

page(s)

26

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1156914

Prevalence, trends, and factors associated with antipsychotic polypharmacy among Medicaid-eligible schizophrenia patients, 1998-2000.

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1156914

The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2003.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1156914

Dose response and dose equivalence of antipsychotics

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1156914

Practice guideline for the treatment of patients with schizophrenia, second edition.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1156914

Antipsychotic medication use patterns and associated costs of care for individuals with schizophrenia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1156914

Antipsychotic medication coprescribing in a large state hospital system

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1156914

Antipsychotic combination therapy in schizophrenia. A review of efficacy and risks of current combinations

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1156914

Antipsychotic prescribing practices in the Veterans Healthcare Administration--New York metropolitan region

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1156914

Algorithm for treatment-refractory schizophrenia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1156914

Multiple antipsychotic medication prescribing patterns

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1156914

The Texas Medication Algorithm Project (TMAP) schizophrenia algorithms.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1156914

The Texas Medication Algorithm Project: development and implementation of the schizophrenia algorithm.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1156914

Combination antipsychotics: pros, cons, and questions

30 May 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-5-26

Combination antipsychotic therapy in clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-5-26

Antipsychotic prescribing practices in Connecticut's public mental health system: rates of changing medications and prescribing styles

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-5-26

Multiple versus single antipsychotic agents for hospitalized psychiatric patients: case-control study of risks versus benefits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-5-26

Recent trends in antipsychotic combination therapy of schizophrenia and schizoaffective disorder: implications for state mental health policy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-5-26

Cost-effectiveness of risperidone, olanzapine, and conventional antipsychotic medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-5-26

Antipsychotic polypharmacy: a survey of discharge prescriptions from a tertiary care psychiatric institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-5-26

Comparison of risperidone and olanzapine as used under "real-world" conditions in a state psychiatric hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-5-26

The impact of olanzapine, risperidone, or haloperidol on the cost of schizophrenia care in a medicaid population

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-5-26

Effectiveness of atypical antipsychotic medications in reducing violent behavior among persons with schizophrenia in community-based treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-5-26

Polypharmacy in patients with schizophrenia.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1156914

Treatment of schizophrenia 1999. The expert consensus guideline series

28 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15921508

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Antipsychotic polypharmacy: squandering precious resources?

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15921508

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-244X-5-26

1 reference

Dimensions Publication ID

2282716

1042409635

0 references

2282716

1 reference

1 reference

1 reference